{"id":"W2760980960","doi":"10.1371/journal.pone.0185198","title":"Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of British Columbia; Public Health Ontario","funders":"Government of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Palliative care; Psychological intervention; Cost effectiveness; Internal medicine; Oncology; Quality-adjusted life year; Cost-effectiveness analysis; Incremental cost-effectiveness ratio; Nursing","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006727194,0.001168849,0.001659455,0.001728735,0.0002826726,0.001604409,0.001403174,0.0008468654,0.002041268],"category_scores_gemma":[0.02271682,0.0005248369,0.00444481,0.001972466,0.0006452448,0.000879903,0.0007748824,0.001482686,0.0001036042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02157106,"about_ca_system_score_gemma":0.01193043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3022005,"about_ca_topic_score_gemma":0.2149223,"domain_scores_codex":[0.9962871,0.002309696,0.0001884363,0.0002613598,0.000431982,0.0005213448],"domain_scores_gemma":[0.9915332,0.006235596,0.0009306591,0.0001762075,0.0007153513,0.000408868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.00649372,0.0006073703,0.06682619,0.002760279,0.008587759,0.0003957384,0.0001049556,0.8709528,0.0005486911,0.006096583,0.002243286,0.03438263],"study_design_scores_gemma":[0.002337183,0.00401785,0.1411887,0.001295913,0.01169263,0.0006015165,0.0004989958,0.826169,0.0009219361,0.006033507,0.005037056,0.0002058318],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9443756,0.02555778,0.01033906,0.003191171,0.000180167,0.001027893,0.009112925,0.00010129,0.006114157],"genre_scores_gemma":[0.9947747,0.001625842,0.001753798,0.000138113,0.00002306351,0.0001100143,0.001317393,0.000007634852,0.0002494902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3022005,"threshold_uncertainty_score":0.600883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2653111098263065,"score_gpt":0.3435191924587082,"score_spread":0.07820808263240164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}